What is the address of Dr. Sebastian J. Faict, orthopedisch chirurg?

The registered office of Dr. Sebastian J. Faict, orthopedisch chirurg is located at Lindendries 115, 1730 Asse.

Is Dr. Sebastian J. Faict, orthopedisch chirurg still active?

Yes. According to the CBE (1 October 2026) Dr. Sebastian J. Faict, orthopedisch chirurg is active, legal situation “Normale toestand”, started on 8 October 2019.

Is Dr. Sebastian J. Faict, orthopedisch chirurg registered on Peppol?

No, Dr. Sebastian J. Faict, orthopedisch chirurg is currently not registered on the Peppol network.

What is the enterprise number of Dr. Sebastian J. Faict, orthopedisch chirurg?

The enterprise number of Dr. Sebastian J. Faict, orthopedisch chirurg is BE0735846849.

When was Dr. Sebastian J. Faict, orthopedisch chirurg founded?

Dr. Sebastian J. Faict, orthopedisch chirurg was founded on 8 October 2019.

Who are the directors of Dr. Sebastian J. Faict, orthopedisch chirurg?

According to the 2025 annual accounts, the directors of Dr. Sebastian J. Faict, orthopedisch chirurg are: Sebastian Faict.

Is Dr. Sebastian J. Faict, orthopedisch chirurg a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 October 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Sebastian J. Faict, orthopedisch chirurg make in 2025?

Dr. Sebastian J. Faict, orthopedisch chirurg posted a profit after taxes of € 306,282 in financial year 2025.

What is the revenue of Dr. Sebastian J. Faict, orthopedisch chirurg?

As a small company, Dr. Sebastian J. Faict, orthopedisch chirurg is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 400,479.

Dr. Sebastian J. Faict, orthopedisch chirurg (Private Limited)

Dossier Dr. Sebastian J. Faict, orthopedisch chirurg, printed on 1 October 2026 from databakkes.be/en/0735846849/dr-sebastian-j-faict-orthopedisch-chirurg. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 29 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. Sebastian J. Faict, orthopedisch chirurg from Asse, company number BE0735846849, closed financial year 2025 with a result of € 306,282 after tax. For that financial year Dr. Sebastian J. Faict, orthopedisch chirurg recorded a gross margin of € 400,479 and equity of € 37,019. Compared with financial year 2024, the result moved from € 267,664 to € 306,282. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 23, 2025.

What it is worth Healthy

€ 37,019

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 306,282

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 63,520

▼ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 306,282 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,310

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 11,172

▲ € 8,547 vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 152,559 Gross margin 2022: € 152,559 First fiscal year in the series	€ 333,683 Gross margin 2023: € 333,683 ▲ 119% vs 2022 (€ 152,559) Favourable step	€ 347,684 Gross margin 2024: € 347,684 ▲ 4% vs 2023 (€ 333,683) Favourable step	€ 400,479 Gross margin 2025: € 400,479 ▲ 15% vs 2024 (€ 347,684) Favourable step	▲ 15%
Profit after taxes	€ 118,382 Profit after taxes 2022: € 118,382 First fiscal year in the series	€ 254,246 Profit after taxes 2023: € 254,246 ▲ 115% vs 2022 (€ 118,382) Favourable step	€ 267,664 Profit after taxes 2024: € 267,664 ▲ 5% vs 2023 (€ 254,246) Favourable step	€ 306,282 Profit after taxes 2025: € 306,282 ▲ 14% vs 2024 (€ 267,664) Favourable step	▲ 14%
Equity	€ 231,821 Equity 2022: € 231,821 First fiscal year in the series	€ 236,067 Equity 2023: € 236,067 ▲ 2% vs 2022 (€ 231,821) Favourable step	€ 37,019 Equity 2024: € 37,019 ▼ 84% vs 2023 (€ 236,067) Unfavourable step	€ 37,019 Equity 2025: € 37,019 Unchanged (€ 37,019) Unchanged
Total debts	€ 61,031 Total debts 2022: € 61,031 First fiscal year in the series	€ 39,927 Total debts 2023: € 39,927 ▼ 35% vs 2022 (€ 61,031) Favourable step	€ 504,400 Total debts 2024: € 504,400 ▲ € 464,473 vs 2023 (€ 39,927) Unfavourable step	€ 225,001 Total debts 2025: € 225,001 ▼ 55% vs 2024 (€ 504,400) Favourable step	▼ 55%
Cash	€ 235,883 Cash 2022: € 235,883 First fiscal year in the series	€ 222,983 Cash 2023: € 222,983 ▼ 5% vs 2022 (€ 235,883) Unfavourable step	€ 183,954 Cash 2024: € 183,954 ▼ 18% vs 2023 (€ 222,983) Unfavourable step	€ 63,520 Cash 2025: € 63,520 ▼ 65% vs 2024 (€ 183,954) Unfavourable step	▼ 65%
Retained profit	€ 229,821 Retained profit 2022: € 229,821 First fiscal year in the series	€ 234,067 Retained profit 2023: € 234,067 ▲ 2% vs 2022 (€ 229,821) Favourable step	€ 35,019 Retained profit 2024: € 35,019 ▼ 85% vs 2023 (€ 234,067) Unfavourable step	€ 35,019 Retained profit 2025: € 35,019 Unchanged (€ 35,019) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 250,000 Dividend 2023: € 250,000 Unchanged (€ 0) Unchanged	€ 466,712 Dividend 2024: € 466,712 ▲ 87% vs 2023 (€ 250,000) Unchanged	€ 306,282 Dividend 2025: € 306,282 ▼ 34% vs 2024 (€ 466,712) Unchanged	▼ 34%
Balance sheet total	€ 292,852 Balance sheet total 2022: € 292,852 First fiscal year in the series	€ 275,993 Balance sheet total 2023: € 275,993 ▼ 6% vs 2022 (€ 292,852) Unchanged	€ 541,419 Balance sheet total 2024: € 541,419 ▲ 96% vs 2023 (€ 275,993) Unchanged	€ 262,020 Balance sheet total 2025: € 262,020 ▼ 52% vs 2024 (€ 541,419) Unchanged	▼ 52%

Key figures of Dr. Sebastian J. Faict, orthopedisch chirurg, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Dr. Sebastian J. Faict, orthopedisch chirurg?

What happened at Dr. Sebastian J. Faict, orthopedisch chirurg in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 23, 2025 New annual accounts for financial year 2025: profit of € 306,282 (▲ 14% vs 2024). Source: NBB ↗
Oct 8, 2019 New establishment in Asse. KBO
Oct 8, 2019 Start of the company according to the CBE. KBO

In short

From € 118,382 profit in 2022 to € 306,282 profit in 2025.

Paid € 292,414 in corporate taxes since 2022.

Best year ever: 2025, with € 306,282 profit.

Paid out € 1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Sebastian J. Faict, orthopedisch chirurg? We notify you, reason included.

Follow Dr. Sebastian J. Faict, orthopedisch chirurg

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sebastian Faict

Dr. Sebastian J. Faict, orthopedisch chirurg

NOEL & PARTNERS

ORTHOPEDIE-TRAUMATOLOGIE AZORG

Behind Dr. Sebastian J. Faict, orthopedisch chirurg is Sebastian Faict. Sebastian Faict is also behind NOEL & PARTNERS and ORTHOPEDIE-TRAUMATOLOGIE AZORG.

See the full network in the app

Directors

According to the 2025 annual accounts

Sebastian Faict

Director

Also active at: NOEL & PARTNERS, ORTHOPEDIE-TRAUMATOLOGIE AZORG

Establishments

Establishment units

Physical locations of this company

Registered office

Lindendries 115

1730 Asse

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0735.846.849
VAT number: BE 0735.846.849
Registered office: Lindendries 115, 1730 Asse
Names & denominations: Dr. Sebastian J. Faict, orthopedisch chirurg
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 October 2019
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗